Public Health Agency of Canada / Agence de santé public du Canada
Skip first menu Skip all menus Français Contact Us Help Search Canada Site
Home Centers & Labs Publications Guidelines A-Z Index
Check the help on Web Accessibility features Child Health Adult Health Seniors Health Surveillance Health Canada
Public Health Agency of Canada

 

 

Current Avian influenza (H5N1) affected areas

Recognition, reporting and testing of Severe Respiratory Illness (SRI), including severe influenza-like illness (severe ILI), in current avian influenza (H5N1) affected countries:

Health care Providers:

Continued vigilance is recommended for the surveillance, recognition, reporting and prompt investigation of patients with unexpected outcomes of severe influenza-like illness (severe ILI*) who are linked to H5N1 avian flu-affected areas (Table 1). For specific recommendations regarding screening, laboratory investigations and reporting, please consult your local or provincial/territorial health authorities.

_____________________
* Influenza-like illness (ILI) in the general population (FluWatch national case definition): Acute onset of respiratory illness with fever and cough and with one or more of the following - sore throat, arthralgia, myalgia, or prostration which could be due to influenza virus. In children under 5, gastrointestinal symptoms may also be present. In patients under 5 or 65 and older, fever may not be prominent.
Severe ILI may include complications such as: pneumonia, Acute Respiratory Distress Syndrome (ARDS), encephalitis and other severe and life threatening complications requiring hospitalization or resulting in death of otherwise healthy individuals.

Hospitals:

Enhanced SRI surveillance in hospitals is aimed at early detection of a re-emergence of SARS as well as other emerging respiratory infections, including novel influenza viruses of pandemic potential. Presently, enhanced surveillance is recommended for severe respiratory illness (including severe ILI) in persons linked to H5N1 avian flu-affected areas as well as SARS-affected areas.

Table 1, below, provides an up-to-date list of countries experiencing human cases of H5N1 avian influenza. For detailed background and recommendations on enhanced SRI surveillance in hospitals, please consult your local or provincial/territorial health authorities. Also see Health Canada’s enhanced surveillance for Severe or Emerging Respiratory Illness. PDF

TABLE 1: Confirmed Cases of Human Avian Influenza (H5N1)

Avian influenza (H5N1)
Third Wave (Dec 2004 - present)
WHO Confirmed human cases
(Updated 6 February 2006)
Location
Total # of human cases
Total deaths
Cambodia
4
4
Thailand
5
2
Vietnam
66
22
Indonesia
23
16
China
10
7
Turkey
12 (9)*
4
Iraq
1
1

Note: this table will be updated as new information becomes available.

*These cases have been confirmed by the Ministry of Health in Turkey and in situation updates by the WHO. Only 12 of the cases have been officially verified by the WHO collaborating laboratory in the UK.

For additional information, please refer to the Cumulative Number of Confirmed Human Cases of Avian Influenza A/(H5N1) Reported to WHO New window

TABLE 2: Countries with OIE confirmed H5N1 Avian Influenza in Poultry

Presence of Highly Pathogenic Avian Influenza (H5N1) in poultry based on OIE* confirmed cases
(Updated 3 Feb. 2006 )

(1 July 2005 to present)

Affected Country

First date of outbreak

Most recent date of outbreak

Total # of outbreaks since
1 Dec 2005

Total # of confirmed outbreaks in poultry

Indonesia Aug 2005 Dec 2005 1 36
China1 1 Aug 2005 1 Jan 2006 2 30
Vietnam 9 July 2005 17 Dec 2005 66 477
Thailand 5 July 2005 9 Nov 2005 0 75
Romania1 7 Oct 2005 10 Jan 2006 27 37
Russia1 23 July 2005 7 Dec 2005 1 60
Turkey1 1 Oct 2005 19 Jan 2006 52 56
Ukraine 25 Nov 2005 16 Jan 2006 44 49

* World Organisation for Animal Health
1 H5N1 has also been identified in wild birds in areas of this country.

Latest Avian Influenza Map: FAO Bi-weekly Avian Influenza Maps New window

 

Last Updated: 2006-02-06 Top